⚠ EN DIRECT — European Consumer Safety Watch 💊 Médicaments: 18 au cours des 7 derniers jours 🍎 Alimentation: 180 au cours des 7 derniers jours 🧸 Produits: 48 au cours des 7 derniers jours 🟢 Surveillance: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Dernière récupération: il y a 2 heures ⚠ EN DIRECT — European Consumer Safety Watch 💊 Médicaments: 18 au cours des 7 derniers jours 🍎 Alimentation: 180 au cours des 7 derniers jours 🧸 Produits: 48 au cours des 7 derniers jours 🟢 Surveillance: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Dernière récupération: il y a 2 heures
🛡️ EUSW
🇫🇷
💊

Comirnaty

COVID-19 mRNA vaccine
Infection par le virus COVID-19
✅ Autorisé
Aucune alerte active
Ce médicament ne fait l'objet ni de pénuries en cours, ni de lettres de sécurité, ni de rappels.

À quoi ça sert

Comirnaty JN.1 dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations. Comirnaty JN.1 concentrate for dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in infants and children aged 6 months to 11 years. The use of this vaccine should be in accordance with official recommendations. Comirnaty KP.2 dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations. Comirnaty KP.2 concentrate for dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in infants and children aged 6 months to 4 years. The use of this vaccine should be in accordance with official recommendations. Comirnaty LP.8.1 dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations. Comirnaty LP.8.1 concentrate for dispersion for injection is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in infants and children aged 6 months to 4 years. The use of this vaccine should be in accordance with official recommendations.

⚠️ Sécurité des patients

No

⚠️ Nous agrégeons des avis officiels. Nous ne donnons pas d'avis médical. Pour toute décision médicale ou juridique, consultez l'agence source et un professionnel qualifié.